LVTX — LAVA Therapeutics NV Share News
0.000.00%
Last trade - 00:00- $45.77m
- -$3.89m
- $11.98m
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 07:29 PM
Brief: Xoma Royalty Announces Closing Of Transactions To Acquire Lava Therapeutics N.V.
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Xoma Royalty And Lava Therapeutics Announce Amendment To Purchase Agreement
Lava Therapeutics Nv Reports Results For The Quarter Ended June 30: Earnings Summary
Lava Therapeutics Nv Expected To Post A Loss Of 25 Cents A Share: Earnings Preview
Brief: XOMA Royalty to acquire LAVA Therapeutics for $1.16-$1.24 per share
Lava Therapeutics Nv Reports Results For The Quarter Ended March 31: Earnings Summary
Lava Therapeutics Nv Expected To Post A Loss Of 31 Cents A Share: Earnings Preview
Brief: Lava Therapeutics Granted Full Waiver For RVO Payment Obligation
Lava Therapeutics Nv Reports Results For The Quarter Ended December 31: Earnings Summary
Brief: LAVA Therapeutics Q4 Basic EPS USD -0.14
Lava Therapeutics Nv Expected To Post A Loss Of 29 Cents A Share: Earnings Preview
Lava Therapeutics Nv Expected To Post A Loss Of 29 Cents A Share: Earnings Preview
Brief: LAVA Therapeutics NV Receives Nasdaq Non-Compliance Notice For Minimum Bid Price
U.S. STOCKS ON THE MOVE-Maze Therapeutics, UFP Technologies, Itron
U.S. STOCKS ON THE MOVE-AxoGen, Portillo, Cisco Systems